This study highlights a potential link between germline CDKN2A c.301G>T mutations and increased susceptibility to OSCC, contributing to the growing evidence that CDKN2A mutation carriers may be at an elevated risk for HNSCC. Here, CDKN2A is linked to head and neck squamous cell carcinoma.